Predicting drug-drug interactions in vitro and in silico
What is it about?
This chapter describes in vitro-in vivo correlations and focuses on drug-drug interactions with CYPs, transporters and nucler receptors. In silico approaches are also described in this area.
Why is it important?
Suggests the importance of in vitro and in silico approaches as a combined effort to predict DDI. It has deep coverage of IVIVC.
The following have contributed to this page: Dr Sean Ekins